首页> 外文期刊>Journal of the Saudi Heart Association >50. Primary PCI for STEMI patients at KACC: Has patient’s access and hospital outcome improved over the last 5 years?
【24h】

50. Primary PCI for STEMI patients at KACC: Has patient’s access and hospital outcome improved over the last 5 years?

机译:50. KACC的STEMI患者的主要PCI:在过去5年中,患者的可及性和住院结局是否有所改善?

获取原文
           

摘要

Primary PCI (pPCI) is Class1 indication to treat patients (pts) with S-T elevation Myocardial Infarction (STEMI). In 2010, 56% of STEMI pts presented to KACC were treated with pPCI with hospital mortality of 2.3% compared to 11.3% for those who did not qualify mainly due to late presentation. We aim to compare pts access, reason for no access to pPCI and hospital outcome 5 yrs on. Data from 2010 at KACC showed relatively low access to pPCI for STEMI pts primarily due to late presentation and initial thrombolysis. We believe that pts access to pPCI would have improved over the last 5 years due to improved public awareness and expanding evidenced-based health provision. This is a retrospective study to analyze and compare data for STEMI pts during 2010 (G1 = 223 pts) and those treated between August 2014 and August 2015 (G2 = 288 pts). We compared demographic and baseline characteristics, pts access, reason for no access and hospital mortality for the two groups. We used student-t test to compare continuous variables and Chi-square test to compare categorical onesOf the 288 pts in G2, 247 pts (85%) were males with average age of 57 yrs. 49% were diabetics, 48% hypertensive, 48% were smokers and 27% were obese. These were not different in G1. Of G2, 164 pts (57%) only had access to pPCI compared to 56% in G1 ( p = 0.536-NS). In G2, the main reasons for no pPCI was late presentation in 47% vs 53% in G1; P = 0.34-NS and 27% due to thrombolysis vs 17% in G1 ( p = 0.11NS). Hospital mortality in G2 was 4% in those treated with pPCI compared to 2.3% in G1 ( P = 0.522-NS). Mortality In pts who did not receive pPCI in G2 was 8% compared to 11.3% in G1 ( p = 0.49-NS). Females in G2 has about 3 times higher mortality. Compared to 2010, pts treated for STEMI in the last 12 months at KACC still have same, relatively low access to pPCI due mainly to persistent pattern of late presentation and prior thrombolysis which reflect apparent lack of direct access to hospitals with pPCI facilities. This seemingly relates to both lack of public awareness and health provision factors in pPCI organizations. Hospital mortality rate for pts treated with pPCI remained low during the two era while pts who did not qualify for pPCI showed a trend towards improved survival.
机译:主要PCI(pPCI)是治疗S-T升高型心肌梗死(STEMI)的患者(pts)的1类适应症。在2010年,接受PCI手术的STEMI患者中有56%接受了pPCI治疗,住院死亡率为2.3%,而那些主要由于晚期就诊而不合格的患者,其住院死亡率为11.3%。我们的目的是比较pts的访问,pPCI无法访问的原因和5年后的医院结局。来自KACC的2010年数据显示,STEMI pts进入pPCI的机会相对较低,这主要是由于晚期呈报和初始溶栓。我们认为,由于公众意识的提高和基于证据的医疗服务的扩展,过去五年来,患者获得pPCI的机会将会有所改善。这是一项回顾性研究,以分析和比较2010年STEMI pts(G1 = 223 pts)和2014年8月至2015年8月之间的STEMI pts(G2 = 288 pts)。我们比较了两组的人口统计学和基线特征,pts访问,无法访问的原因以及医院死亡率。我们使用Student-t检验比较连续变量,使用卡方检验比较分类变量。在G2的288分中,有247分(85%)是男性,平均年龄为57岁。糖尿病患者占49%,高血压患者占48%,吸烟者占48%,肥胖者占27%。这些在G1中没有什么不同。在G2中,只有164分(57%)可以使用pPCI,而在G1中只有56%(p = 0.536-NS)。在G2中,没有pPCI的主要原因是47%的患者迟发,而G1中的53%。 P = 0.34-NS,由于溶栓而占27%,而在G1中为17%(p = 0.11NS)。用pPCI治疗的患者中G2的医院死亡率为4%,而G1的为2.3%(P = 0.522-NS)。在G2中未接受pPCI的患者中,死亡率为8%,而G1中为11.3%(p = 0.49-NS)。 G2区的女性死亡率高出约3倍。与2010年相比,在KACC过去12个月中接受STEMI治疗的患者仍然有相同的pPCI相对较低的访问权限,这主要是由于持续出现晚期症状和先前的溶栓作用,这表明明显缺乏直接使用pPCI设施的医院。看来这与pPCI组织中缺乏公众意识和健康提供因素有关。在两个时代中,接受pPCI治疗的患者的医院死亡率仍然较低,而不符合pPCI资格的患者则显示出生存率提高的趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号